Advertisements

Stocking Stuffers

 

iCo Therapeutics Inc. (ICO:CA) Stock Quote

Detailed Quote for iCo Therapeutics Inc (ICO:CA)
$ 0.085 0.00 (0.00%) Volume: 6.25k 9:30 AM EDT 26-Mar-2019
Today 5d 1m 3m 1y more
Last Price
0.085
Change $
Change %
Tick
  
Bid
0.08
Bid Size
301,000
Ask
0.085
Ask Size
67,000
Open
0.085
High
0.085
Low
0.085
Prev Close
0.085
Last Trade
9:30
Volume
6.25k
52 Wk Hi
0.275000005
52 Wk Low
0.029999999
Market Cap
9.3m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
109,457,713
EPS (TTM)
-0.019999999
PE Ratio
N/A
Exchange
TSXV
News and Media for iCo Therapeutics Inc (ICO:CA)
Sector News | Topic News
News for iCo Therapeutics Inc (ICO:CA)
Tue, Mar 05, 2019
7:26 AM iCo Therapeutics Inc. Announces the Issuance of 3,600,000 Units Pursuant to its Non-Brokered Private Placement - Newsfile
Mon, Feb 25, 2019
8:01 AM iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Units Pursuant to its C$1,250,000 Non-Brokered Private Placement - Newsfile
Tue, Feb 19, 2019
6:01 AM iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Private Placement to $1,250,000 CDN - Newsfile
5:46 AM iCo Therapeutics Inc. Announces Notice of Termination of Sub License for Bertilimumab (iCo-008) - Newsfile
Mon, Feb 11, 2019
7:20 PM iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Units Pursuant to its C$750,000 Non-Brokered Private Placement - Newsfile
Thu, Jan 31, 2019
8:07 PM iCo Therapeutics Inc. Announces Non-Brokered Private Placement to Raise C$750,000 - Newsfile
Thu, Nov 29, 2018
5:00 PM iCo Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Update - Newsfile
Thu, Nov 15, 2018
8:01 AM iCo Therapeutics Provides Corporate Update, Including Drug Supply for Next Oral Amphotericin B Efficacy Study - Newsfile
Tue, Oct 23, 2018
8:00 AM iCo Therapeutics Announces Oral Amphotericin B Clinical Advisory Board - Newsfile
Tue, Oct 02, 2018
8:01 AM iCo Therapeutics Provides Corporate Update - Newsfile
Thu, Sep 06, 2018
8:00 AM iCo Therapeutics Announces Additional Positive Pharmacokinetic Results and Presentation at Global Investment Conference - Newsfile
Wed, Aug 29, 2018
6:32 PM iCo Therapeutics Announces Second Quarter 2018 Financial Results And Corporate Update - Newsfile
Mon, Jul 16, 2018
8:01 AM iCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials - Phase 1 Oral Amphotericin B - Newsfile
Wed, Jun 27, 2018
8:00 AM iCo Therapeutics Announces Positive Clinical Outcome - Primary Endpoint Met in Phase 1 Oral Amphotericin B Study - Newsfile
Wed, Jun 20, 2018
8:00 AM iCo Therapeutics Provides Corporate Update, Announces Completion of Phase 1 Recruitment - Newsfile
Wed, May 30, 2018
4:18 PM iCo Therapeutics Announces First Quarter 2018 Financial Results And Update On Phase 1 Clinical Trial - Newsfile
Tue, Apr 24, 2018
8:47 PM iCo Therapeutics Announces Year End 2017 Financial Results - Newsfile
Wed, Apr 18, 2018
8:00 AM iCo Therapeutics Announces Major Milestone - Dosing of First Patient for its Oral Amphotericin B Phase 1 Clinical Study - Newsfile
Tue, Nov 28, 2017
5:00 PM iCo Therapeutics Announces Third Quarter 2017 Financial Results - Newsfile
Wed, Nov 22, 2017
1:45 PM IIROC Trading Resumption - ICO - Canada Newswire
More News for ICO:CA >>

Tags for iCo Therapeutics Inc.

Research stocks or mutual funds related to iCo Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ICO:CA. The keywords below have been associated to ICO:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock